Anebulo Pharmaceuticals, Inc. (ANEB)
OTCMKTS · Delayed Price · Currency is USD
0.3200
-0.0050 (-1.54%)
At close: Sep 28, 2026
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $13.05 million as of September 28, 2026. Its market cap has decreased by -86.76% in one year.
Market Cap
13.05M
Enterprise Value
4.01M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.32
ChartMarket Cap Chart
Since May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from 165.19M to 13.05M, a decrease of -92.10%. That is a compound annual growth rate of -37.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 13.05M | -68.55% |
| Dec 31, 2025 | 41.50M | -4.76% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -13.09% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EOM Pharmaceuticals Holdings | 20.51M |
| Inhibitor Therapeutics | 17.38M |
| Finch Therapeutics Group | 16.62M |
| Synlogic | 13.72M |
| ZIVO Bioscience | 13.70M |
| Oncotelic Therapeutics | 11.58M |
| Brainstorm Cell Therapeutics | 10.70M |
| Zeo ScientifiX | 10.66M |